A Phase II, Double-Blind Placebo-Controlled Study to Determine the Prophylactic Efficacy of Oral BTA798 in an Experimental Rhinovirus Challenge Model

| Country :
| organs :
| Specialty :

Extract

1) To evaluate the efficacy of BTA798 in preventing HRV infection 2) To evaluate the efficacy of BTA798 in preventing upper respiratory tract illness.

Inclusion criteria

BTA798 is an investigational drug being developed as a potential agent for treatment and prevention of the common cold

Kusajili – Clinical trials directory

A Phase II, Double-Blind Placebo-Controlled Study to Determine the Prophylactic Efficacy of Oral BTA798 in an Experimental Rhinovirus Challenge Model

Extract

Inclusion criteria

Links